Rhythm Pharmaceuticals
The Scientific Affairs Manager will serve as a trusted scientific partner to external experts and decision makers in Germany, supporting Rhythm's rare genetic disease of obesity portfolio. The role involves building peer‑to‑peer relationships, supporting clinical trial execution, and developing scientific communication plans for setmelanotide, while ensuring compliance with local regulations.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
22% below the average for this role
Senior Manager, Medical & Scientific Affairs
ANI Pharmaceuticals
Medical Affairs (Rare Disease)
AstraZeneca
Medical Science Liaison, Rare Disease (Central)
Ipsen
Global Medical Affairs Asset Lead (GMAL) Rare Disease
lifelancer
Medical Affairs
AstraZeneca
Rare Disease – Severe Active MPA/GPA & Sjogren’s Disease MSL
The Christian Broadcasting Network (CBN)